Abbott today announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of its ...

Scientists have identified no less than 16 distinct types of nerve cells in the human dorsal root ganglion (DRG), ...

Furthermore, a global Tiam1 deletion in mice or a conditional Tiam1 deletion from spinal dorsal horn neurons or from dorsal ...

Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.

Abbott has launched a “next-generation” delivery system to streamline the electrode implantation process for its Proclaim DRG neurostimulation system. This advancement aims to improve treatments for ...

Researchers have used genetic tools to investigate how specific nerve cells in the brain respond after a spinal cord injury.